February 28, 2019
Galderma’s skin acne targeting cream meets all goals in Phase three test
Galderma’s Phase 3 “Perfect” 2 clinical trials of Trifarotene, an investigational drug, against acne, with 2,400 patients met all primary and secondary efficacy endpoints, the company said Thursday.